drugset / Trial / NCT00296491

Study Of Allergic Rhinitis In Patients Who Also Have Asthma

NCT00296491

Phase 4 Completed 725 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs used in this study are approved for the age group under study.

Timeline

Start
2005-09
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 100 ug Intranasal
Comparator Fluticasone propionate Other / unclassified 200 ug Intranasal
Comparator Montelukast Other / unclassified 10 mg
Comparator Salmeterol Other / unclassified 50 ug

Indications